Scientific article

Manifestations pulmonaires de la sclérodermie systémique

Published inRevue médicale suisse, vol. 11, no. 469, p. 802-806
Publication date2015

Systemic sclerosis (SSc) is a protean disorder in which prognosis and treatment are tailored on the basis of organ involvement. Among SSc lung manifestations, interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH) or the combination of both, are the first cause of SSc mortality and impact heavily on patient quality of life. ILD may begin early in disease and usually progresses slowly. However, approximately 10% of patients with ILD may reach terminal respiratory insufficiency. PAH may be an early or late complication of SSc in which increased blood pressure in pulmonary arteries leads to right heart failure. Current treatments provide some benefit, but both SSc-ILD and PAH still represent an enormous unmet need of more efficacious therapeutic strategies.

  • Blood Pressure
  • Disease Progression
  • Health Services Needs and Demand
  • Humans
  • Hypertension, Pulmonary/etiology/physiopathology/therapy
  • Lung Diseases, Interstitial/etiology/physiopathology/therapy
  • Prognosis
  • Quality of Life
  • Scleroderma, Systemic/complications/mortality/therapy
Citation (ISO format)
POSA, Magdalena et al. Manifestations pulmonaires de la sclérodermie systémique. In: Revue médicale suisse, 2015, vol. 11, n° 469, p. 802–806.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation10/18/2015 3:28:00 PM
First validation10/18/2015 3:28:00 PM
Update time03/15/2023 12:03:38 AM
Status update03/15/2023 12:03:38 AM
Last indexation01/16/2024 8:01:23 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack